Zobrazeno 1 - 10
of 206
pro vyhledávání: '"Roberto Frussa-Filho"'
Autor:
Eduardo A. V. Marinho, Alexandre Justo Oliveira-Lima, Henrique S. Reis, Renan Santos-Baldaia, Raphael Wuo-Silva, Andre W. Hollais, Thais S. Yokoyama, Roberto Frussa-Filho, Lais F. Berro
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: The endocannabinoid system has been implicated in the neurobiology of opioid use disorder. While the CB1 receptor antagonist rimonabant has been shown to block some of the behavioral effects of opioids, studies suggest that the treatmen
Externí odkaz:
https://doaj.org/article/06e597525fbb4f4aaa9bacb52c49a35e
Autor:
Raphael Wuo-Silva, Daniela F. Fukushiro-Lopes, Bruno P. Fialho, André W. Hollais, Renan Santos-Baldaia, Eduardo A. V. Marinho, Elisa Mári-Kawamoto, Thaís S. Yokoyama, Leonardo B. Lopes-Silva, Laís F. Berro, Roberto Frussa-Filho, Beatriz M. Longo
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Studies on the abuse potential of modafinil, a psychostimulant-like drug used to treat narcolepsy, are still controversial. While some studies claim no potential for abuse, increasing evidence suggests that modafinil induces abuse-related effects, in
Externí odkaz:
https://doaj.org/article/81df5af6542148249698756b61e422ba
Autor:
Cláudio Fontes Souza, Lúcia Garcez-do-Carmo, Isaltino Marcelo Conceição, Thalma Ariani Freitas, Roberto Frussa-Filho
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 50, Iss 4, Pp 757-764 (2014)
Chronic antidepressant administration increases neurotrophin levels in the central and peripheral nervous system, leading to an increase of neuronal sprouting, reestablishment of neural networks and neurotransmitter levels. Injured peripheral nerves
Externí odkaz:
https://doaj.org/article/44d40c7743f94aabad4a1a549cdac4bf
Autor:
Welinton Alessandro Oliveira de Almeida, Andrea Maculano Esteves, Canuto Leite de Almeida-Júnior, Kil Sun Lee, Miriam Kannebley Frank, Melise Oliveira Mariano, Roberto Frussa-Filho, Sergio Tufik, Marco Tulio de Mello
Publikováno v:
Sleep Science, Vol 7, Iss 4, Pp 203-208 (2014)
Long-term treatments with dopaminergic agents are associated with adverse effects, including augmentation. Augmentation consists of an exacerbation of restless legs syndrome (a sleep-related movement disorder) symptoms during treatment compared to th
Externí odkaz:
https://doaj.org/article/cf8337e5faa24fec9949c83c7b3ebe9b
Autor:
Raphael Wuo-Silva, Daniela Fukushiro, André Hollais, Renan Baldaia, Elisa Kawamoto, Lais F Berro, Thais Yokoyama, Leonardo Lopes-Silva, Carolina Bizerra, Roberta Procópio-Souza, Debora Hashiguchi, Lilian Figueiredo, José L Costa, Roberto Frussa-Filho, Beatriz Monteiro Longo
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
There is substantial controversy about the addictive potential of modafinil, a wake-promoting drug used to treat narcolepsy, proposed as pharmacotherapy for cocaine abuse, and used indiscriminately by healthy individuals due to its positive effects o
Externí odkaz:
https://doaj.org/article/bac5270f599d44eaa5e1eb2bbcb531bf
Autor:
Michele Rechia Fighera, Luiz Fernando Freire Royes, Ana Flávia Furian, Mauro Schneider Oliveira, Natália Gindri Fiorenza, Roberto Frussa-Filho, João Carlos Petry, Rafael Correa Coelho, Carlos Fernando Mello
Publikováno v:
Neurobiology of Disease, Vol 22, Iss 3, Pp 611-623 (2006)
Monosialoganglioside (GM1) is a glycosphingolipid that protects against some neurological conditions, such as seizures and ischemia. Glutaric acidemia type I (GA-I) is an inherited disease characterized by striatal degeneration, seizures, and accumul
Externí odkaz:
https://doaj.org/article/2046a9c0a62443df8fac072c238c39ba
Autor:
Roberto Frussa-Filho, Sonia R. Kameda, Lineane H.F. Zanlorenci, E. Mári-Kawamoto, Mariana Bendlin Calzavara, J.M. Costa, P.H. Zanier-Gomes, Roberta Procópio-Souza, T.F. Trombin, R. Wuo-Silva, Luciana T.C. Ribeiro, Daniela F. Fukushiro
Publikováno v:
Pharmacology Biochemistry and Behavior. 173:90-95
Opioid addiction is a growing public health problem, being currently considered an epidemic in the United States. Investigating the behavioral effects of opioids and the factors influencing their development becomes of major importance. In animals, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c9a2cc7b1006d65f6b0c025d7cb4f5
https://doi.org/10.1016/j.pbb.2018.07.006
https://doi.org/10.1016/j.pbb.2018.07.006
Autor:
Luciana T.C. Ribeiro, Renan Santos-Baldaia, Laís F. Berro, Beatriz M. Longo, Thais S. Yokoyama, Eduardo A.V. Marinho, F. Talhati, Roberto Frussa-Filho, Alexandre J. Oliveira-Lima, M.A. Baldaia, A.W. Hollais, Raphael Wuo da Silva
Publikováno v:
Pharmacology Biochemistry and Behavior. 156:16-23
CB1 receptor antagonists have been shown to prevent acute and long-term behavioral effects of cocaine. Here we evaluate the effectiveness of the CB1 receptor antagonist rimonabant to modify sensitized responses to cocaine. Mice were treated with sali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88f973db5896d33114cb758f7a93f795
https://doi.org/10.1016/j.pbb.2017.03.006
https://doi.org/10.1016/j.pbb.2017.03.006
Autor:
Eduardo A.V. Marinho, Renan Santos-Baldaia, Thaísa Barros-Santos, A.W. Hollais, Matheus Libarino-Santos, Roberto Frussa-Filho, Ana Catherine Gomes de Santana Santos, Aurea Lorena Nunes Borges, M.A. Baldaia, Nina Rosa Nunes Brandão, Elisangela G. Cata-Preta, Laís F. Berro, Alexandre J. Oliveira-Lima
Publikováno v:
Drug and alcohol dependence. 208
Background Evidence suggests that aripiprazole, a partial dopamine D2 and serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist, show significant efficacy in reducing alcohol use. We have previously demonstrated that treatment with aripipr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f245e1d34b3ba09ae2961928a7aad72
https://pubmed.ncbi.nlm.nih.gov/31954952
https://pubmed.ncbi.nlm.nih.gov/31954952
Autor:
R. Wuo-Silva, Luciana T.C. Ribeiro, Camilla L. Patti, Karina A. Zanin, Leonardo B. Lopes-Silva, Aline R. Borçoi, Roberto Frussa-Filho, Stephanie B. Grapiglia, A.W. Hollais, L.M.B. Ceccon, Renan Santos-Baldaia, Laís F. Berro
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 63:63-69
Background Prenatal environmental adversities may affect brain development and are associated with increased risk for schizophrenia, an illness with 50% comorbidity with addiction. Maternal immune activation by poly-inosinic–citidilic acid (Poly(I:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3666c864a3f45c554c30fc876a337c0
https://doi.org/10.1016/j.pnpbp.2015.05.015
https://doi.org/10.1016/j.pnpbp.2015.05.015